Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 4
2010 2
2011 2
2012 2
2013 1
2014 1
2015 1
2016 1
2017 2
2018 3
2019 5
2020 4
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship.
Epstein-Shochet G, Pham S, Beck S, Naiel S, Mekhael O, Revill S, Hayat A, Vierhout M, Bardestein-Wald B, Shitrit D, Ask K, Montgomery AB, Kolb MR, Surber MW. Epstein-Shochet G, et al. Among authors: kolb mr. Pulm Pharmacol Ther. 2020 Aug;63:101933. doi: 10.1016/j.pupt.2020.101933. Epub 2020 Aug 1. Pulm Pharmacol Ther. 2020. PMID: 32750409 Free article.
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
Tsai APY, Hur SA, Wong A, Safavi M, Assayag D, Johannson KA, Morisset J, Fell C, Fisher JH, Manganas H, Shapera S, Cox G, Gershon AS, Hambly N, Khalil N, To T, Wilcox PG, Halayko A, Kolb MR, Ryerson CJ. Tsai APY, et al. Among authors: kolb mr. Thorax. 2021 Jan;76(1):37-43. doi: 10.1136/thoraxjnl-2020-214944. Epub 2020 Oct 6. Thorax. 2021. PMID: 33023996
Fibrocytes in chronic lung disease--facts and controversies.
Maharaj SS, Baroke E, Gauldie J, Kolb MR. Maharaj SS, et al. Among authors: kolb mr. Pulm Pharmacol Ther. 2012 Aug;25(4):263-7. doi: 10.1016/j.pupt.2011.09.002. Epub 2011 Sep 20. Pulm Pharmacol Ther. 2012. PMID: 21951688 Review.
30 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page